Perich Carmen, Ricós Carmen, Marqués Fernando, Minchinela Joana, Salas Angel, Martínez-Bru Cecilia, Boned Beatriz, Gómez-Rioja Rubén, Cortés Marià, González-Lao Elisabet, García Lario Jose Vicente, Tejedor Xavier, Bullich Sandra, Ventura Montserrat, González-Tarancón Ricardo, Fernández-Fernández Pilar, Ramón Francisco, Corte Zoraida, Llopis Antonia Ma, Díaz-Garzón Jorge, Simón Margarita, Fernández-Calle Pilar
Comité de Programas Externos de la SEQC-ML, Barcelona, Spain.
Comisión de Calidad Analítica de la SEQC-ML, Barcelona, Spain.
Adv Lab Med. 2020 May 19;1(2):20200019. doi: 10.1515/almed-2020-0019. eCollection 2020 Jun.
The purpose of this study is to understand the evolution of the analytical performance of the laboratories participating in the Spanish society of laboratory medicine (SEQC) external quality assurance (EQA) programmes during its 30 years of operation and to compare it with the performance of other EQA programmes to establish whether the results are similar. The results obtained during this period are evaluated by applying the biological variability (BV) and state of the art-derived quality specifications. In addition, the results are compared with those obtained by other EQA programme organisations. It is noted that the laboratories participating in the EQA-SEQC programmes have improved their performance over 30 years of experience and that the specifications derived from biological variation are achievable. It is difficult to compare EQA programmes, due to lack of accessibility and the differences in the design of these programmes (control materials, calculations used and analytical specifications established). The data from this study show that for some biological magnitudes the results obtained by the programmes are not yet harmonised, although efforts are being made to achieve this. Organisers of EQA programmes should also join the harmonisation effort by providing information on their results to enable comparison.
本研究的目的是了解参与西班牙检验医学学会（SEQC）外部质量保证（EQA）计划的实验室在其30年运营期间分析性能的演变，并将其与其他EQA计划的性能进行比较，以确定结果是否相似。通过应用生物学变异（BV）和最新的质量规范来评估在此期间获得的结果。此外，将结果与其他EQA计划组织获得的结果进行比较。值得注意的是，参与EQA-SEQC计划的实验室在30年的经验中提高了其性能，并且源自生物学变异的规范是可以实现的。由于缺乏可及性以及这些计划设计上的差异（对照材料、使用的计算方法和确立的分析规范），很难对EQA计划进行比较。本研究的数据表明，对于某些生物学指标，尽管正在努力实现，但各计划获得的结果尚未统一。EQA计划的组织者也应通过提供其结果信息以实现比较，加入到统一的努力中来。
